BIA
AGIO icon

Bell Investment Advisors’s Agios Pharmaceuticals AGIO Stock Holding History

Bell Investment Advisors’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.8K Hold
237
– – ﹤0.01% 753
2026
Q1 		$8.02K Sell
237
-44
-16% -$1.25K ﹤0.01% 773
2025
Q4 		$7.65K Sell
281
-17
-6% -$596 ﹤0.01% 800
2025
Q3 		$12K Hold
298
– – ﹤0.01% 569
2025
Q2 		$9.91K Buy
298
+61
+26% +$1.85K ﹤0.01% 678
2025
Q1 		$6.95K Hold
237
– – ﹤0.01% 757
2024
Q4 		$7.79K Hold
237
– – ﹤0.01% 711
2024
Q3 		$10.5K Hold
237
– – ﹤0.01% 597
2024
Q2 		$10.2K Hold
237
– – ﹤0.01% 602
2024
Q1 		$6.93K Hold
237
– – ﹤0.01% 743
2023
Q4 		$5.28K Buy
237
+206
+665% +$4.62K ﹤0.01% 852
2023
Q3 		$768 Buy
+31
New +$820 ﹤0.01% 1645
2023
Q1 		– Sell
-156
Closed -$4.38K – 1911
2022
Q4 		$4.38K Hold
156
– – ﹤0.01% 878
2022
Q3 		$4K Sell
156
-32
-17% -$858 ﹤0.01% 745
2022
Q2 		$4K Buy
+188
New +$4.25K ﹤0.01% 761
2021
Q4 		$7K Buy
213
+131
+160% +$5.27K ﹤0.01% 586
2021
Q3 		$4K Buy
+82
New +$3.96K ﹤0.01% 762

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Bell Investment Advisors's AGIO Position: Q2 2026 in Review

Bell Investment Advisors held its Agios Pharmaceuticals (AGIO) position steady in Q2 2026 at 237 shares worth $8.8K. The position accounts for ﹤0.01% of the portfolio, ranked #753.

Bell Investment Advisors first reported a position in AGIO in Q3 2021 and has held it in 17 quarters since. The position peaked at $12K in Q3 2025. 238 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

  • Bell Investment Advisors held 237 shares of Agios Pharmaceuticals worth $8.8K as of Q2 2026.
  • Bell Investment Advisors left its Agios Pharmaceuticals share count unchanged in Q2 2026.
  • Agios Pharmaceuticals made up ﹤0.01% of Bell Investment Advisors's portfolio in Q2 2026, its #753 holding.
  • Bell Investment Advisors first reported a position in Agios Pharmaceuticals in Q3 2021 and has held it in 17 quarters since.
  • Bell Investment Advisors's Agios Pharmaceuticals position peaked at $12K in Q3 2025.
  • 238 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on Bell Investment Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.